+44 (0) 20 7079 4399
Call HCA from 8am-8pm Mon-Fri and 9am-5pm Sat
HCA Healthcare UK
Dr Paula Wells
PhD MRCP FRCR
Urological Cancers, Thoracic Cancers
Urological (bladder, prostate) and lung (including Mesothelioma) cancers (chemotherapy & radiotherapy)
Dr Paula Wells oncology training was undertaken at St. Bartholomew's, UCLH and Mount Vernon Hospitals; following her Fellowship, she undertook a postgraduate research degree at Imperial College School of Medicine, Hammersmith Hospital. There she investigated the potential for Positron Emission Tomography to demonstrate the biological effects of chemotherapy in tissue. She has published a number of papers in this area and was awarded a PhD for her work. Subsequently she completed her post doctoral training at the Royal Marsden Hospital, principally with the Academic Urology Unit.Dr Wells specializes in the management of patients with genitourinary (bladder and prostate) and thoracic (lung and mesothelioma) malignancies.Since taking up her present post she has been extensively involved with the development of the genitourinary and thoracic cancer services for the North East London Cancer Network.She is an active participant in UK clinical trials and is principal investigator for the North East London Cancer Network for ten active studies.From these activities she has been involved with the development of Intensity Modulated Radiotherapy for treatment of prostate cancer, and chemo-radiation in bladder and lung cancer for the Trust. Her research interest in Positron Emission Tomography continues to develop with an emphasis on investigating the direct effects of radiotherapy on tissue and the effect of integration of novel therapies with radiation.
To make an appointment, call HCA on +44 (0)20 7079 4399 or
Call the contact centre
+44 (0) 20 7079 4399
8am-8pm Mon-Fri, 9am-5pm Sat
Let us call you backCan we call you back at a more convenient time
Email contact centreSend us an email and we will get back to you.
© copyright 2008 - 2016 HCA Healthcare UK.
Registered Name: HCA International Limited; The part of the UK in which it is registered: England and Wales;
Registered Number: 03020522; Registered Office Address: 242 Marylebone Road London NW1 6JL.
£500m has been invested by HCA International in the latest medical technologies and facilities over the last 10 years.
Your hospital will be one of our world-class private hospitals: HCA’s world-class hospitals are accredited by The CHKS Accreditation Unit, a leading provider of healthcare intelligence and quality improvement services. The accreditation is a measure of the overall quality of a hospital and hospitals with CHKS accreditation have been shown to provide a better quality of service.
Your safety will be protected because we have more critical care beds than any other private hospital group: HCA hospitals achieved 100% compliance with all Care Quality Commission inspected outcomes of care in 2011.
Your treatment will be undertaken using the most advanced diagnostic and treatment facilities: Oliver Wyman, Corporate Accounts: Driving quality and value, January 2012.